BG100476A - Съединения за медицинска употреба - Google Patents

Съединения за медицинска употреба Download PDF

Info

Publication number
BG100476A
BG100476A BG100476A BG10047696A BG100476A BG 100476 A BG100476 A BG 100476A BG 100476 A BG100476 A BG 100476A BG 10047696 A BG10047696 A BG 10047696A BG 100476 A BG100476 A BG 100476A
Authority
BG
Bulgaria
Prior art keywords
acetyl
alanyl
glucosaminyl
acetylmuramyl
cancer
Prior art date
Application number
BG100476A
Other languages
Bulgarian (bg)
English (en)
Inventor
��Ris �In�Gin
Original Assignee
Peptech (Uk) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech (Uk) Limited filed Critical Peptech (Uk) Limited
Publication of BG100476A publication Critical patent/BG100476A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Silicon Compounds (AREA)
  • Silicon Polymers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BG100476A 1993-10-08 1996-04-03 Съединения за медицинска употреба BG100476A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939320820A GB9320820D0 (en) 1993-10-08 1993-10-08 Compounds for medicinal use
PCT/GB1994/002167 WO1995010293A1 (en) 1993-10-08 1994-10-05 Compounds for medicinal use

Publications (1)

Publication Number Publication Date
BG100476A true BG100476A (bg) 1996-12-31

Family

ID=10743251

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100476A BG100476A (bg) 1993-10-08 1996-04-03 Съединения за медицинска употреба

Country Status (17)

Country Link
US (1) US5877147A (de)
EP (1) EP0722332B1 (de)
JP (1) JP3954644B2 (de)
KR (1) KR100337977B1 (de)
AT (1) ATE183397T1 (de)
AU (1) AU680302B2 (de)
BG (1) BG100476A (de)
CA (1) CA2173322A1 (de)
CZ (1) CZ99796A3 (de)
DE (1) DE69420145T2 (de)
GB (1) GB9320820D0 (de)
HU (1) HUT75530A (de)
IL (1) IL111198A0 (de)
LV (1) LV11595B (de)
SK (1) SK42396A3 (de)
WO (1) WO1995010293A1 (de)
ZA (1) ZA947894B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9413935D0 (en) * 1994-07-11 1994-08-31 Peptech Uk Ltd Use of maramyl peptide compounds
WO1997005889A1 (en) * 1995-08-03 1997-02-20 Slesarev Vladimir I Non-specific vaccination by d-amino-acid containing compounds
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
US7947275B2 (en) * 2000-05-10 2011-05-24 Signe Biopharma, Inc. Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
US7863011B2 (en) * 2000-05-10 2011-01-04 Signe Biopharma, Inc. Screening method for predicting susceptibility to breast cancer
US6867238B2 (en) * 2001-06-22 2005-03-15 Gerhard N. Schrauzer Compositions for the treatment and prevention of cancer
US7211258B2 (en) * 2002-04-10 2007-05-01 Protalex, Inc. Protein A compositions and methods of use
US7425331B2 (en) * 2002-04-10 2008-09-16 Protalex, Inc. Protein A methods of use
US7112564B2 (en) * 2003-04-09 2006-09-26 Zylacta Corporation Biodegradable glucosaminemuramyl peptides for apoptosis modulation
WO2005007676A2 (en) * 2003-07-10 2005-01-27 Rajadhyaksha V J Glycopeptides for the treatment of als and other metabolic and autoimmune disorders
AU2007240946A1 (en) * 2006-04-20 2007-11-01 Sciclone Pharmaceuticals, Inc. Treatment of melanoma
MX2009008641A (es) * 2007-02-13 2009-09-14 Sciclone Pharmaceuticals Inc Composiciones para el tratamiento o prevencion del deterioro, lesion o daño a tejido debido a enfermedad de las mucosas.
EP2271352A4 (de) 2008-04-01 2014-01-15 Innate Therapeutics Ltd Zusammensetzungen und verfahren zur behandlung von neoplastischen erkrankungen
NZ571665A (en) * 2008-09-30 2011-01-28 Innate Therapeutics Ltd Compositions and methods for treatment of radiation exposure utilising cross-linked muramyl dipeptide microparticles
RU2571551C1 (ru) * 2015-04-16 2015-12-20 Закрытое акционерное общество "ПЕПТЕК" Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором
CA3021645A1 (en) 2016-04-29 2017-11-02 Icahn School Of Medicine At Mount Sinai Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis
AU2022239614A1 (en) 2021-03-19 2023-10-12 Icahn School Of Medicine At Mount Sinai Compounds for regulating trained immunity, and their methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
JPS6033120B2 (ja) * 1977-11-15 1985-08-01 第一製薬株式会社 新規ムラミルジペプチド誘導体
DE2862107D1 (en) * 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
JPS5519236A (en) * 1978-07-27 1980-02-09 Dai Ichi Seiyaku Co Ltd Muramyl dipeptide derivative
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
US5189014A (en) * 1979-12-03 1993-02-23 Cowan Jr Fred M Method of treating cellular Fc receptor mediated hypersensitivity immune disorders
US4684625A (en) * 1982-07-08 1987-08-04 Syntex (U.S.A.) Inc. Method for enhancing the anti-infective activity of muramyldipeptide derivatives
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4774085A (en) * 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4774058A (en) * 1985-09-26 1988-09-27 Mehl Ehrenfried L Apparatus for, and methods of, operating upon a fluid
HU205147B (en) * 1989-06-29 1992-03-30 Sandoz Ag Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same
CA2123912C (en) * 1991-11-19 2007-04-17 Roger Aston Muramyl compounds for treatment of septic shock

Also Published As

Publication number Publication date
ATE183397T1 (de) 1999-09-15
JP3954644B2 (ja) 2007-08-08
ZA947894B (en) 1996-04-09
HU9600887D0 (en) 1996-06-28
LV11595B (en) 1997-06-20
KR100337977B1 (ko) 2002-10-09
EP0722332B1 (de) 1999-08-18
AU7789094A (en) 1995-05-04
HUT75530A (en) 1997-05-28
JPH09503776A (ja) 1997-04-15
DE69420145D1 (de) 1999-09-23
DE69420145T2 (de) 1999-12-09
CA2173322A1 (en) 1995-04-20
WO1995010293A1 (en) 1995-04-20
US5877147A (en) 1999-03-02
LV11595A (en) 1996-12-20
CZ99796A3 (en) 1996-09-11
SK42396A3 (en) 1997-01-08
GB9320820D0 (en) 1993-12-01
AU680302B2 (en) 1997-07-24
IL111198A0 (en) 1995-12-08
EP0722332A1 (de) 1996-07-24

Similar Documents

Publication Publication Date Title
BG100476A (bg) Съединения за медицинска употреба
EP0614369B1 (de) Pharmazeutische Dipeptid Zusammensetzungen und Verwendungsmethoden.
US6139862A (en) Pharmaceutical dipeptide compositions and methods of use thereof
EP0615522B1 (de) Muramylverbindungen zur behandlung von septischem schock
JPH03181422A (ja) 炎症の治療方法及び炎症の治療用合成薬
AU668088B2 (en) Pharmaceutical dipeptide compositions and methods of use thereof
CA2194678A1 (en) Use of muramyl peptide compounds
CZ86197A3 (en) Use of muramyl peptide compounds
CN1265799C (zh) 含锌化合物和谷氨酰胺类的组合物
WO1998009989A1 (en) The use of muramylpeptides in the treatment of myelosuppressed or otherwise immunocompromised states
WO2008003013A2 (en) Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic
ES2357245T3 (es) Inhibidor de los pólipos intestinales.
FR2477551A1 (fr) Nouveaux derives de l'a, a'-trehalose et medicaments les contenant
WO1999003504A1 (en) Medicinal compositions for treating immunodeficiency diseases
RU96109376A (ru) Соединения для применения в медицине
WO2006105317A2 (en) Antitumorigemic drug combination comprising a vegf-inhibitor and a thrombospondin-1 peptidomimetic